Association between second-generation antipsychotics and newly diagnosed treated diabetes mellitus: does the effect differ by dose?

Association between second-generation antipsychotics and newly diagnosed treated diabetes mellitus: does the effect differ by dose?

<p>Abstract</p> <p>Background</p> <p>The benefits of some second-generation antipsychotics (SGAs) must be weighed against the increased risk for diabetes mellitus. This study examines whether the association between SGAs and diabetes differs by dose.</p> <p>...

Full description

Bibliographic Details
Main Authors: Ulcickas Yood Marianne, DeLorenze Gerald N, Quesenberry Charles P, Oliveria Susan A, Tsai Ai-Lin, Kim Edward, Cziraky Mark J, McQuade Robert D, Newcomer John W, L'Italien Gilbert J
Format: Article
Language:English
Published: BMC 2011-12-01
Series:BMC Psychiatry
Online Access:http://www.biomedcentral.com/1471-244X/11/197

Internet

http://www.biomedcentral.com/1471-244X/11/197

Similar Items